MENU

TBPH Theravance Biopharma Forecast, Technical & Fundamental Analysis

a developer of small molecule pharmaceutical products

Industry Biotechnology
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TBPH is expected to report earnings to fall 23.19% to -19 cents per share on March 03

Theravance Biopharma TBPH Stock Earnings Reports
Q4'24
Est.
$-0.20
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.13
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.02
The last earnings report on November 12 showed earnings per share of -25 cents, missing the estimate of -23 cents. With 212.95K shares outstanding, the current market capitalization sits at 478.47M.
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

TBPH and Stocks

Correlation & Price change

A.I.dvisor tells us that TBPH and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TBPH and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+1.63%
ELEV - TBPH
30%
Poorly correlated
+4.66%
CDXS - TBPH
30%
Poorly correlated
+0.36%
BLPH - TBPH
28%
Poorly correlated
N/A
BPMC - TBPH
28%
Poorly correlated
+1.14%
OABI - TBPH
28%
Poorly correlated
-0.79%
More